Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Aug 11;29(8):5664-5681.
doi: 10.3390/curroncol29080447.

Are Columnar Cell Lesions the Earliest Non-Obligate Precursor in the Low-Grade Breast Neoplasia Pathway?

Affiliations
Review

Are Columnar Cell Lesions the Earliest Non-Obligate Precursor in the Low-Grade Breast Neoplasia Pathway?

Sarah Strickland et al. Curr Oncol. .

Abstract

Columnar cell lesions (CCLs) of the breast comprise a spectrum of morphologic alterations of the terminal duct lobular unit involving variably dilated and enlarged acini lined by columnar epithelial cells. The World Health Organization currently classifies CCLs without atypia as columnar cell change (CCC) and columnar cell hyperplasia (CCH), whereas flat epithelial atypia (FEA) is a unifying term encompassing both CCC and CCH with cytologic atypia. CCLs have been increasingly recognized in stereotactic core needle biopsies (CNBs) performed for the assessment of calcifications. CCLs are believed to represent the earliest non-obligate precursor of low-grade invasive breast carcinomas as they share molecular alterations and often coexist with entities in the low-grade breast neoplasia pathway. Despite this association, however, the risk of progression of CCLs to invasive breast carcinoma appears low and may not exceed that of concurrent proliferative lesions. As the reported upgrade rates of pure CCL/FEA when identified as the most advanced high-risk lesion on CNB vary widely, the management of FEA diagnosed on CNB remains controversial. This review will include a historical overview of CCLs and will examine histologic diagnostic criteria, molecular alterations, prognosis and issues related to upgrade rates and clinical management.

Keywords: breast; carcinogenesis; columnar cell lesions; low-grade neoplasia; precursor.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Columnar cell change (CCC) showing variably sized and shaped (a,c) acini lined by one to two layers of columnar-shaped epithelial cells with uniform, ovoid to elongated nuclei oriented perpendicular to the basement membrane; apical cytoplasmic snouts are seen at the luminal surface and an outer layer of myoepithelial cells is evident (b,df). There are luminal secretions (a,c,d) and calcifications (d,f).
Figure 2
Figure 2
Columnar cell hyperplasia (CCH) showing variably dilated acini lined by more than two layers of columnar-shaped cells with (a,c,e,f) with nuclear crowding and overlapping, and formation of small tufts (b,d). There are luminal secretions (a,b,e) and calcifications (c,d,f).
Figure 3
Figure 3
Flat epithelial atypia (FEA) composed of variably dilated acini (a,c) with calcifications (a,b) and low-grade cytologic atypia characterized by the presence of rounded or ovoid nuclei with loss of polarity, mildly increased nuclear to cytoplasmic ratio and prominent nucleoli in some cells (b,df).
Figure 4
Figure 4
Columnar cell lesion (CCL) with foci of architectural complexity comprising focal formation of a micropapillary structure (a,b,e) and cribriforming with rigid cellular bridges (c,d,f) associated with low-grade cytologic atypia, consistent with atypical ductal hyperplasia.

Similar articles

Cited by

References

    1. Hoon Tan P.H., Ellis I., Allison K., Brogi E., Fox S.B., Lakhani S., Lazar A.J., Morris E.A., Sahin A., Salgado R., et al., editors. World Health Organization Classification of Tumours of the Breast. 5th ed. IARC Press; Lyon, France: 2019. - PubMed
    1. Kim M.J., Kim E.-K., Oh K.K., Park B.-W., Kim H. Columnar Cell Lesions of the Breast: Mammographic and US Features. Eur. J. Radiol. 2006;60:264–269. doi: 10.1016/j.ejrad.2006.06.013. - DOI - PubMed
    1. Verschuur-Maes A.H.J., van Gils C.H., van den Bosch M.A.A.J., De Bruin P.C., van Diest P.J. Digital Mammography: More Microcalcifications, More Columnar Cell Lesions without Atypia. Mod. Pathol. 2011;24:1191–1197. doi: 10.1038/modpathol.2011.81. - DOI - PubMed
    1. Luiten J.D., Korte B., Voogd A.C., Vreuls W., Luiten E.J.T., Strobbe L.J., Rutten M.J.C.M., Plaisier M.L., Lohle P.N., Hooijen M.J.H., et al. Trends in Frequency and Outcome of High-Risk Breast Lesions at Core Needle Biopsy in Women Recalled at Biennial Screening Mammography, a Multiinstitutional Study. Int. J. Cancer. 2019;145:2720–2727. doi: 10.1002/ijc.32353. - DOI - PMC - PubMed
    1. Said S.M., Visscher D.W., Nassar A., Frank R.D., Vierkant R.A., Frost M.H., Ghosh K., Radisky D.C., Hartmann L.C., Degnim A.C. Flat Epithelial Atypia and Risk of Breast Cancer: A Mayo Cohort Study. Cancer. 2015;121:1548–1555. doi: 10.1002/cncr.29243. - DOI - PMC - PubMed